Hospice and palliative care is a Medicare-reimbursed segment of the healthcare continuum focused on comfort-oriented end-of-life care for patients with terminal diagnoses and a six-month or less prognosis. The industry is largely driven by an aging Baby Boomer population, rising chronic disease prevalence, and increasing clinical and family preference for home-based end-of-life care over hospitalization. It is heavily regulated by CMS, subject to annual Medicare reimbursement rate adjustments, and faces ongoing compliance scrutiny related to eligibility documentation, billing integrity, and referral relationships.
Who buys these: Private equity-backed healthcare platforms, regional home health and hospice roll-up operators, strategic acquirers including larger hospice chains, and occasionally high-net-worth individuals with healthcare operational experience
4–7×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Typically $1M–$5M revenue with $300K–$1.5M EBITDA; Medicare-certified with at least 2 years of operational history; ADC (average daily census) of 40–150 patients; clean compliance record with no active CMS investigations; diversified referral network with no single referral source exceeding 20% of admissions; licensed in states with favorable CON or non-CON environments
Get Deal Flow In Your Inbox
New Hospice & Palliative Care acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Hospice & Palliative Care acquisition
Seller Intelligence
Who sells Hospice & Palliative Care businesses?
Founder-operators who are nurses, physicians, or social workers that built independent hospice agencies; aging entrepreneurs seeking retirement exits after 10–20 years of operation; small regional hospice owners facing increasing regulatory complexity and reimbursement pressure
Typical exit timeline: 12–24 months
Hospice & Palliative Care businesses in the $1M–$5M revenue range typically sell for 4–7× EBITDA. Typically $1M–$5M revenue with $300K–$1.5M EBITDA; Medicare-certified with at least 2 years of operational history; ADC (average daily census) of 40–150 patients; clean compliance record with no active CMS investigations; diversified referral network with no single referral source exceeding 20% of admissions; licensed in states with favorable CON or non-CON environments
Hospice & Palliative Care businesses typically trade at 4–7× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Hospice & Palliative Care businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Asset purchase with Medicare provider agreement novation and a 10–20% seller note or earnout tied to census retention post-close
Key due diligence areas include: Medicare cost reports, cap calculations, and reimbursement history including any overpayment or recoupment exposure; Clinical compliance records including QAPI data, survey deficiencies, and any OIG or CMS enforcement actions; Referral source concentration, physician relationships, and anti-kickback statute compliance documentation; Staff licensure, turnover rates, and employment agreements for key clinical personnel including DON and Administrator; Payer mix analysis, ADC trends, length-of-stay data, and live discharge rates as indicators of operational quality.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers